© 2019 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230

Vasoptic Medical Testing Device to Detect Diabetes-Caused Blindness

March 15, 2013

 

Early-stage life sciences startup Vasoptic Medical has been testing a hand-held device that can be used by primary care physicians for the early detection of diabetic retinopathy. That’s damage to the retina caused by diabetes that can lead to blindness.

 

BmoreMedia reports:

 

The tests, being held at the Johns Hopkins Wilmer Eye Institute, are required for federal Food and Drug Administration approval. When done in 2014, the Columbia company will seek FDA clearance to market and sell the device.

 

While the startup estimates “it will cost $7.5 million to bring the device to market,” each device will sell for around $10,000.

 

For full story click here.

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 30, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 24, 2017

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

Vasoptic receives another patent issuance from The United States Patent and Trademark Office (USPTO)

November 15, 2016

1/10
Please reload